Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
OTC Drugs

Firms To Gear Up For Japan’s Approaching OTC Law, Expected Market Growth

This article was originally published in The Tan Sheet

  • News
  • The Tan Sheet

Executive Summary

Firms are preparing for regulations taking effect in April 2009 that are expected to grow Japan's OTC market by allowing for expanded consumer access to nonprescription products

You may also be interested in...



In Japan, Online Retailers Miss Out On OTC Deregulation

Japan expanded consumer access to OTC drugs and some nutritional supplements on June 1, but faces challenges to its ban on online sales of the products

In Japan, Online Retailers Miss Out On OTC Deregulation

Japan expanded consumer access to OTC drugs and some nutritional supplements on June 1, but faces challenges to its ban on online sales of the products

In Japan, Online Retailers Miss Out On OTC Deregulation

Japan expanded consumer access to OTC drugs and some nutritional supplements on June 1, but faces challenges to its ban on online sales of the products

Table

View full table

Related Content

HBW Insight

Topics

Tags:
OTC Drugs
Latest Headlines

Pharma Can Pursue Claims Against Providers For 340B Duplicate Discounts In Medicaid Managed Care, HRSA Says

The Aspirin Test For AI?

Mary Beth Clarke, CDER Exec Programs Office Director And Generic User Fee Shepherd, Will Retire

Rx Advertising: Interchangeability Doesn’t Mean Clinical Superiority To Other Biosimilars, FDA Says

See All
UsernamePublicRestriction

Register

PS102026

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By